Nasal NKT lymphoma is a type of peripheral T-cell lymphoma that has a poor prognosis, ranging from a few months to several years, but fewer than 40% of patients survive for several years.
The most common type of NK/T-cell lymphoma is the extranodal NK/T-cell lymphoma nasal type. This type of lymphoma is more common in Asia than in Europe and the United States, and is the most common type of peripheral T-cell lymphoma in China, accounting for 40% to 50% of all peripheral T-cell lymphomas.
It is more common in young men, and the tumor is often confined to the nasal cavity or invades adjacent tissues. Early-stage lesions account for 70% to 90% of cases. Common signs and symptoms include nasal congestion or rhinorrhea and enlarged lymph nodes in the neck.
Early-stage lesions can often be survived for a longer period of time with radiotherapy, and in the case of advanced-stage lesions, the survival period is often shorter, even if radiotherapy is combined with chemotherapy treatment. Drugs include gemcitabine, oxaliplatin, cyclophosphamide, pembrolase, and so on.
Specific diagnosis and treatment need to be directed by a physician.